NanoEcho has been granted 300 SEK from Vinnova to develop an application for the EIC Accelerator Open Call. The support co-finances the work of designing a complete application for the EU's funding programme for innovations with high growth potential. The project is carried out in collaboration with GAEU Consulting and includes the development of an initial “Short Proposal” followed by a full application. If the application is approved, it could provide significant funding for NanoEcho’s continued work on clinical validation and commercialization of the company’s rectal cancer diagnostic system.
|
Published October 10, 2025
NanoEcho receives Vinnova support for EIC application
Text:
News Desk [email protected]
Notes
Sofinnova Partners raises EUR 650 million in new fund
Merck acquires Cidara for approximately USD 9,2 billion
Coegin Pharma launches first Follicopeptide product
Ascelia Pharma receives FDA acceptance for Orviglance application
Diamyd Medical passes safety review ahead of Phase III readout
Egetis reports positive results from the ReTRIACt study
Mikael Dolsten withdraws his nomination to Novo's board
NEWSLETTER
Today's news roundup
News roundup Monday, November 17
Upcoming events
MedTech Summit 2026
A new, much-needed MedTech forum in one of Europe's leading life science clusters. As the first event of its kind...
Recommended
Pila Pharma stands out in next-generation obesity pipeline
Novo Nordisk challenges Pfizer in billion-dollar battle for Metsera
New major investment will strengthen Europe's life science sector
The pharmaceutical sector is riding a USD 61,6 billion R&D wave
SwedenBIO wants to give growth power to the industry
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account